Leerink Partners首次覆盖Avalo Therapeutics,给予“跑赢大盘”评级,目标价38美元

美股速递
Jul 06

投资银行Leerink Partners日前宣布,正式启动对生物制药公司Avalo Therapeutics Inc.的研究覆盖,并给予其股票“跑赢大盘”的评级。分析师为该股设定的目标价格为每股38美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10